Bio-Techne Corporation (TECH) has experienced various shifts, being able to maintain a steady growth through varied market situations. The company boasts of a strong trading day, outperforming competitors. The asset is held by several entities including Asset Management One Co. Ltd, Sage Mountain Advisors LLC, Ownership Capital B.V., Sumitomo Mitsui Trust Group Inc, and Nordea Investment Management AB. Bio-Techne has continued to innovate with solutions like the ProximityScope to study protein interactions, influenced by ties with Oxford Nanopore Technologies. Earnings have been generally positive but have seen some dips as the economic environment continues to be uncertain. Bio-Techne has also seen several new partnerships including with Spear Bio, utilizing their technology to deliver ultrasensitive biomarker detection. The firm plans to present at upcoming investor conferences and has announced exosome diagnostics divestiture and a share repurchase program.
Bio-Techne Corp TECH News Analytics from Wed, 05 Feb 2025 08:00:00 GMT to Sat, 01 Nov 2025 08:58:49 GMT -
Rating 7
- Innovation 8
- Information 8
- Rumor 2
